Sort
25,944 grants matching “neurodegeneration”
Amyloid, white matter hyperintensities & outcomes of late-life depression
$461,383Meryl A Butters · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · MH
Investigating the role of CSPalpha in presynaptic autophagy
$461,313Sreeganga S Chandra · Yale University · R21 · FY2025 · AG
Redox-sensitive activation of REDD1 in diabetic retinopathy
$461,273Michael D. Dennis · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2025 · EY
Muli-scale Structural Imaging of Alzheimer's Disease Neuropathology and Neurodegeneration
$461,108David H Salat · Massachusetts General Hospital · R21 · FY2021 · AG
Alzheimer's tauopathy phenotype and the microRNA22-3p: implication for pathogenesis
$461,070Domenico Pratico · Temple Univ Of The Commonwealth · R01 · FY2022 · AG
Murine Transgenic Models of Prion Diseases
$460,958David A Harris · Boston University Medical Campus · R01 · FY2014 · NS
Psychophysical Correlates of Neurodegeneration in Glaucoma
$460,944Peter John Bex · Schepens Eye Research Institute · R01 · FY2012 · EY
Psychophysical Correlates of Neurodegeneration in Glaucoma
$460,944Peter John Bex · Schepens Eye Research Institute · R01 · FY2011 · EY
Ligand Regulated Epigenetic/Nuclear Architectural Strategies and Human Disease
$460,934Michael G Rosenfeld · University Of California, San Diego · R01 · FY2012 · NS
Genetic etiology of Amyotrophic Lateral Sclerosis
$460,861Bryan Traynor · National Institute On Aging · ZIA · FY2011 · AG
Association of LOY with Other Forms of Genome Instability
$460,849Cristina Montagna · Rutgers Biomedical And Health Sciences · R21 · FY2025 · AG
LRRK2 Enzymatic Mechanisms of Neurodegeneration in Parkinson's Disease
$460,750Darren John Moore · Van Andel Research Institute · R01 · FY2024 · NS
Ubiquitin Signaling
$460,696Peter Kaiser · University Of California-Irvine · R01 · FY2018 · GM
Chronic sialidase effects on amyloid aggregation and associated pathology
$460,676Michael P McDonald · University Of Tennessee Health Sci Ctr · R01 · FY2010 · AG
Investigating Translational De-repression as a Mechanism to Increase Progranulin Levels in iPSC-derived Patient Neurons
$460,625Sandra Almeida · Univ Of Massachusetts Med Sch Worcester · R21 · FY2019 · NS
Imaging Biomarkers of Exercise-Induced Brain Changes in Parkinson's Disease
$460,625Evan D Morris · Yale University · R21 · FY2020 · NS
Upregulation of progranulin in a human iPSC-derived neurovascular model of GRN-associated Frontotemporal Dementia
$460,625Sandra Almeida · Univ Of Massachusetts Med Sch Worcester · R21 · FY2023 · AG
Generation and trans-neuronal seeding of phosphorylated T217-Tau in aging macaque cortical circuits
$460,625Dibyadeep Datta · Yale University · R21 · FY2022 · AG
Investigating the role of TDP-43 citrullination in ALS pathogenesis
$460,625Francesca Massi · Univ Of Massachusetts Med Sch Worcester · R21 · FY2025 · NS
Mechanistic Investigation of Innate Immunity in a Drosophila Model of Frontotemporal Dementia
$460,625Fen-Biao Gao · Univ Of Massachusetts Med Sch Worcester · R21 · FY2024 · AG
Characterization of TASK-1 Modulation of Dipeptide Repeat Protein-Mediated Toxicity in iPSC-derived C9ORF72 Patient Neurons.
$460,625Sandra Almeida · Univ Of Massachusetts Med Sch Worcester · R21 · FY2020 · NS
Brain Cholesterol Biosynthesis in Health and Neurological Disease
$460,625Angeliki Louvi · Yale University · R21 · FY2022 · NS
Optogenetics and Transgenic Technology Core
$460,579Brandon Harvey · National Institute On Drug Abuse · ZIC · FY2013 · DA
Peripheral BDZ Receptor - Biomarker of Neurotoxicity
$460,562Tomas R Guilarte · Florida International University · R01 · FY2023 · ES
Identification of early markers for Alzheimer's disease by neuroimaging
$460,548Basavaraju Sanganahalli Ganganna · Yale University · R21 · FY2024 · AG